1. Home
  2. CRI vs RAPP Comparison

CRI vs RAPP Comparison

Compare CRI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$34.86

Market Cap

1.3B

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$36.19

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
RAPP
Founded
1865
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2002
2024

Fundamental Metrics

Financial Performance
Metric
CRI
RAPP
Price
$34.86
$36.19
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$34.00
$48.50
AVG Volume (30 Days)
848.4K
240.6K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
24.34
EPS
2.53
N/A
Revenue
$2,898,426,000.00
N/A
Revenue This Year
$4.50
N/A
Revenue Next Year
$1.02
N/A
P/E Ratio
$13.70
N/A
Revenue Growth
1.91
N/A
52 Week Low
$23.38
$7.73
52 Week High
$44.44
$42.27

Technical Indicators

Market Signals
Indicator
CRI
RAPP
Relative Strength Index (RSI) 46.23 72.76
Support Level $31.90 $25.48
Resistance Level $39.05 $42.27
Average True Range (ATR) 1.43 1.97
MACD 0.06 0.58
Stochastic Oscillator 26.75 96.56

Price Performance

Historical Comparison
CRI
RAPP

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: